237 related articles for article (PubMed ID: 30527301)
1. MRI assessment of surrounding tissues in soft-tissue sarcoma during neoadjuvant chemotherapy can help predicting response and prognosis.
Crombé A; Le Loarer F; Stoeckle E; Cousin S; Michot A; Italiano A; Buy X; Kind M
Eur J Radiol; 2018 Dec; 109():178-187. PubMed ID: 30527301
[TBL] [Abstract][Full Text] [Related]
2. High-grade soft-tissue sarcoma: optimizing injection improves MRI evaluation of tumor response.
Crombé A; Le Loarer F; Cornelis F; Stoeckle E; Buy X; Cousin S; Italiano A; Kind M
Eur Radiol; 2019 Feb; 29(2):545-555. PubMed ID: 30039222
[TBL] [Abstract][Full Text] [Related]
3. T
Crombé A; Périer C; Kind M; De Senneville BD; Le Loarer F; Italiano A; Buy X; Saut O
J Magn Reson Imaging; 2019 Aug; 50(2):497-510. PubMed ID: 30569552
[TBL] [Abstract][Full Text] [Related]
4. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
5. Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
Favinger JL; Hippe DS; Davidson DJ; Elojeimy S; Roth ES; Lindberg AW; Ha AS
Acad Radiol; 2018 Apr; 25(4):470-475. PubMed ID: 29273189
[TBL] [Abstract][Full Text] [Related]
6. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
7. Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient Outcome.
Crombé A; Marcellin PJ; Buy X; Stoeckle E; Brouste V; Italiano A; Le Loarer F; Kind M
Radiology; 2019 Jun; 291(3):710-721. PubMed ID: 30964422
[TBL] [Abstract][Full Text] [Related]
8. Impact of residual disease after "unplanned excision" of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution.
Bianchi G; Sambri A; Cammelli S; Galuppi A; Cortesi A; Righi A; Caldari E; Ferrari S; Donati D
Musculoskelet Surg; 2017 Dec; 101(3):243-248. PubMed ID: 28444540
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant treatment with preoperative radiotherapy for extremity soft tissue sarcomas: long-term results from a single institution in Turkey.
Dincbas FO; Oksuz DC; Yetmen O; Hiz M; Dervisoglu S; Turna H; Kantarci F; Mandel NM; Koca S
Asian Pac J Cancer Prev; 2014; 15(4):1775-81. PubMed ID: 24641408
[TBL] [Abstract][Full Text] [Related]
10. Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?
Levy A; Bonvalot S; Bellefqih S; Vilcot L; Rimareix F; Terrier P; Belemsagha D; Cascales A; Domont J; Mir O; Honoré C; Le Cesne A; Le Péchoux C
Eur J Surg Oncol; 2014 Dec; 40(12):1648-54. PubMed ID: 25130960
[TBL] [Abstract][Full Text] [Related]
11. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
12. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy influences the pseudocapsule composition in soft tissue sarcomas.
O'Donnell PW; Manivel JC; Cheng EY; Clohisy DR
Clin Orthop Relat Res; 2014 Mar; 472(3):849-55. PubMed ID: 23640206
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
Tanaka K; Ozaki T
Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
[TBL] [Abstract][Full Text] [Related]
16. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
Schuetze SM; Rubin BP; Vernon C; Hawkins DS; Bruckner JD; Conrad EU; Eary JF
Cancer; 2005 Jan; 103(2):339-48. PubMed ID: 15578712
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative evaluation prior to soft tissue sarcoma excision - Why can't we get it right?
Mesko NW; Wilson RJ; Lawrenz JM; Mathieu JL; Ghiam MK; Mathis SL; Halpern JL; Schwartz HS; Holt GE
Eur J Surg Oncol; 2018 Feb; 44(2):243-250. PubMed ID: 29269109
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissues sarcomas.
Rodrigo RS; Nathalie A; Elodie T; Gonzalo GA; Philippe T; Françoise D; Julien D; Angela C; Bérénice B; Jean-Yves B; Jean-Michel C; Jean B; Sylvie B; Axel le C
Eur J Cancer; 2011 Jun; 47(9):1319-27. PubMed ID: 21450455
[TBL] [Abstract][Full Text] [Related]
19. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
